1. Home
  2. MTRX vs GLSI Comparison

MTRX vs GLSI Comparison

Compare MTRX & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$9.89

Market Cap

281.5M

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$19.63

Market Cap

244.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
GLSI
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.5M
244.7M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MTRX
GLSI
Price
$9.89
$19.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$17.00
$50.00
AVG Volume (30 Days)
366.3K
112.6K
Earning Date
05-06-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
91.51
N/A
EPS
N/A
N/A
Revenue
$873,632,000.00
N/A
Revenue This Year
$19.75
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.56
N/A
52 Week Low
$9.70
$7.78
52 Week High
$15.97
$34.10

Technical Indicators

Market Signals
Indicator
MTRX
GLSI
Relative Strength Index (RSI) 30.06 64.93
Support Level N/A $17.96
Resistance Level $12.48 $19.64
Average True Range (ATR) 0.38 1.08
MACD -0.05 0.34
Stochastic Oscillator 5.51 92.28

Price Performance

Historical Comparison
MTRX
GLSI

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: